ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. G. 附属病院
  2. g 10. 学術雑誌掲載論文
  3. 1. 査読済論文

Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.

http://hdl.handle.net/2297/11554
http://hdl.handle.net/2297/11554
18e13638-9802-46d6-8c55-e72df658b32a
名前 / ファイル ライセンス アクション
PH-PR-MIYAMOTO-K-324.pdf PH-PR-MIYAMOTO-K-324.pdf (411.4 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2017-10-05
タイトル
タイトル Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Jin, Mingji

× Jin, Mingji

WEKO 45999

Jin, Mingji

Search repository
Shimada, Tsutomu

× Shimada, Tsutomu

WEKO 46000

Shimada, Tsutomu

Search repository
Shintani, Miki

× Shintani, Miki

WEKO 46001

Shintani, Miki

Search repository
Yokogawa, Koichi

× Yokogawa, Koichi

WEKO 22233
研究者番号 50283122

Yokogawa, Koichi

Search repository
Nomura, Masaaki

× Nomura, Masaaki

WEKO 26700
e-Rad 20247480
研究者番号 20247480

Nomura, Masaaki

Search repository
Miyamoto, Ken-ichi

× Miyamoto, Ken-ichi

WEKO 22059
研究者番号 30100514

Miyamoto, Ken-ichi

Search repository
提供者所属
内容記述タイプ Other
内容記述 金沢大学附属病院薬剤部
書誌情報 Drug metabolism and pharmacokinetics.

巻 20, 号 5, p. 324-330, 発行日 2005-10-01
ISSN
収録物識別子タイプ ISSN
収録物識別子 1347-4367
NCID
収録物識別子タイプ NCID
収録物識別子 AA1162652X
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.2133/dmpk.20.324
出版者
出版者 日本薬物動態学会 Japanese Society for the Study of Xenobiotics (JSSX)
抄録
内容記述タイプ Abstract
内容記述 We have noticed that the trough level of blood concentration of cyclosporin A (CyA) tends to be lower in patients receiving long-term oral levothyroxine (LTX) than in patients not receiving LTX. We confirmed this clinical observation in experiments using Wistar rats orally given LTX (8 microg/kg) or saline (control) for 3 weeks, followed by CyA (10 mg/kg). The LTX treatment had little effect on the blood concentrations of CyA after i.v. administration, whereas they were decreased significantly after p.o. administration. After p.o. administration, the value of the area under the blood concentration-time curve from 0 to 24 hr and the bioavailability of CyA in the LTX group were decreased to only about one-fifth and a quarter of those in the control group, respectively. After treatment with LTX, the expression levels of mdr1a, mdr1b and CYP3A2 mRNAs in the duodenum were markedly increased to about twice the control, but in jejunum, ileum and liver the expression levels were little changed. These findings suggest that the absorption of CyA, which occurs mainly from the upper intestine, is reduced as a result of efflux transport via P-glycoprotein induced by LTX. In conclusion, careful monitoring of CyA levels is required in the event of LTX administration to patients receiving immunotherapy with CyA.
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-27 12:26:02.553831
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3